Purchase Order 75N95025P00458

Award Date 9/30/25
Potential Completion Date 9/29/27
Potential Value $185K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Children's Research Institute, a pediatric research organization affiliated with Children's National Medical Center. The $176,933.97 contract is for "ADVANCING FETAL PHARMACOLOGY THROUGH REGULATORY SCIENCE" (PERINATAL HEALTH CENTER OF EXCELLENCE) and has a completion date of September 19, 2023. There is no set-aside designation for this award. Children's Research Institute has a strong...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Children's National Hospital, a renowned nonprofit pediatric academic health system, for Autism Neurocognitive Data Support Services. The potential value of this contract is $223,706.94, and the period of performance runs through September 29, 2024. No set-aside designation was used for this award. Children's National Hospital has extensive...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $242,743.16 firm-fixed-price purchase order contract to Children's National Medical Center, doing business as Children's National Hospital, a 323-bed pediatric hospital located in Washington, D.C. The contract has an August 30, 2021 completion date and was awarded on September 21, 2018. The contract is not set aside for a specific socioeconomic program. Children's National Medical...
This federal contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract has a ceiling value of $97,075.45 and is a delivery order contract with a firm fixed price pricing type. The contract was awarded on July 29, 2015 and has an ultimate completion date of September 27, 2016. This contract does not have a set-aside designation....
This is a $170,576 firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Children's Research Institute, a nonprofit pediatric research organization in Washington, D.C. The contract is for a longitudinal research protocol titled "YOUNG AT HEART TYPE 2 DIABETES RESEARCH" and is nonseverable, meaning the work must be completed by the ultimate completion date of August 31, 2026. The contract...
This is a $102,218.75 firm fixed price purchase order awarded by the National Institutes of Health's National Institute on Drug Abuse to the non-profit Child Mind Institute. The contract is for services related to tracking homeostatic regulatory domains in youth in the general community. The work will take place in Bethesda, Maryland and be completed by September 14, 2023. There is no set-aside designation mentioned for this award. The Child Mind Institute is a non-profit organization that...
This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to the non-profit organization Child Mind Institute Inc. The contract, valued at $221,456.00, is for support services to track homeostatic regulatory domains. The contract is not set aside for any special designation. Based on the information provided, the contract involves data collection, analysis, and software...
This is a $49,998.42 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Bar-Haim Yair, a non-profit organization located in Rockville, Maryland. The contract has an ultimate completion date of June 4, 2025 and was awarded on July 3, 2023. The contract does not have a set-aside designation. Based on the agency, this contract is likely related to the National Institute on Drug Abuse's research and programmatic initiatives focused...
This is a $56,470 firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the U.S. Department of Health and Human Services, to Allegheny-Singer Research Institute (AHN Research Institute). The contract does not have a set-aside designation. Through this contract, AHN Research Institute, a non-profit hospital and research organization, is providing services related to the NICHD's research programs. Based...
This federal contract award is for the evaluation of a potential respiratory stimulant on behalf of the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The award, with a ceiling value of $140,848.00, was issued to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The scope of work includes nonclinical animal studies to assess potential treatments for drug-induced respiratory depression and...

This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Children's Research Institute, a non-profit pediatric research organization based in Washington, D.C. The $185,241 contract has an ultimate completion date of September 29, 2027 and was awarded on September 30, 2025. The contract is not set-aside.

Children's Research Institute is a highly active recipient of federal contracts and grants, having secured numerous awards from agencies such as the National Institutes of Health, Defense Health Agency, and National Science Foundation to support a wide range of pediatric healthcare research initiatives, including work on neurological disorders, immunotherapy, rare diseases, and sickle cell disease. This particular contract appears to be part of the institute's ongoing collaborations with federal agencies in advancing understanding and treatment of childhood conditions.

Generated 10/1/25, 10:06 AM